Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Adjuvant in Distal Radius Fracture Block
NCT05274113Phase 3Unknown
- Sponsor
- Rothman Orthopaedics
- Start
- Mar 2022
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in postoperative pain (2 arms), sponsored by Rothman Orthopaedics. Primary endpoints: Postoperative pain control at 72 hours and Postoperative pain control #2 questionnaire at 72 hours. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05274113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05274113.